Patents Assigned to CONVERGENCE MEDICAL, LLC
  • Patent number: 9974512
    Abstract: A method for determining a patient radiation and diagnostic study score associated with past diagnostic radiologic tests. In light of the obvious benefits of diagnostic radiology, the risks inherent in its use are often overlooked. Ionizing radiation, which is a component of much, but not all, diagnostic radiology, carries with it a small risk of inducing cancer every time it is used. This additional risk, known as “Lifetime Attributable Risk,” is layered on top of an individual's lifetime base risk of invasive cancer. The present method for determining a patient radiation and diagnostic study score provides right time, right place, and right format radiology information to assist providers in their medical decision-making. With greater awareness of recent study history, and individually contextualized risk and benefit considerations, providers are more likely to decrease their overall usage of diagnostic radiology and better counsel their patients on future risk.
    Type: Grant
    Filed: March 9, 2015
    Date of Patent: May 22, 2018
    Assignee: CONVERGENCE MEDICAL, LLC
    Inventors: James Huizenga, Brian C. Breneman, Kathleen Huizenga